Most effective
Lose 15–25%
of body weight
Tirzepatide (Mounjaro, Zepbound). Clinical trials show 22.5% mean weight loss at 72 weeks. Compare partner pharmacy prices.
From $349/mo via partner network · Important safety information
Affiliate-supportedIndependent editorialWe never sell medicationSee how
Independent comparison site · Affiliate-supported
We don't sell, prescribe, or ship medications. We surface real cash prices and partner pharmacy options for Wegovy, Zepbound, Ozempic, Mounjaro, and compounded alternatives.
Compare 12 telehealth providers and 14 medications — branded and compounded.
$39–$499/mo rangeTake the quizManufacturer-direct
Free tool
Reveal hidden dose-escalation fees and commitment minimums across 12 providers. See your real 12-month total.
Calculate true costWhat we cover
We don't sell anything. We compare. Every recommendation cites sources and verifies prices weekly.
Side-by-side comparison of independent telehealth providers — we earn affiliate commission, editorial ratings are independent of partnerships.
Weight loss
Compare cash-pay plans from Mochi, Form Health, Henry Meds, Ro and others. Sourced from public provider pricing pages.
Starting from
$199/mo
View comparisonType 2 diabetes
Providers prescribing Ozempic, Mounjaro, Rybelsus and Trulicity. Insurance and cash-pay comparison.
Starting from
$249/mo
View comparisonCompounded
M. in TX switched Ozempic → compounded semaglutide — $8,160/year
2 min ago · illustrative aggregate
What the data says
15-22%
Average body-weight reduction
Semaglutide (Wegovy) ~15% at 68 weeks; tirzepatide (Zepbound) ~22% at 72 weeks (STEP-1, SURMOUNT-1).
70%
Lower cash cost via compounded
Compounded semaglutide telehealth $150-300/mo vs brand Wegovy ~$1,350/mo list price.
12
Telehealth providers compared
Ro, Hims, Henry Meds, Mochi, LifeMD, PlushCare, WeightWatchers Clinic, Found, Calibrate, Eden, SkinnyRx, Hers.
Illustrative aggregate based on published clinical trial outcomes. Individual results vary.
We are a comparison and reference site. We don't prescribe or ship medications.
01 · Prices
Cash prices, dosage tiers, shipping windows. Updated monthly. No login required.
Compare drugs02 · Reference
Ask about dosing, interactions, or side effects. Answers cite the FDA source. Not medical advice.
Ask the assistant03 · Providers
12 partners reviewed for state coverage, dosing flexibility, and cash-pay transparency.
See providersMost effective
Tirzepatide (Mounjaro, Zepbound). Clinical trials show 22.5% mean weight loss at 72 weeks. Compare partner pharmacy prices.
From $349/mo via partner network · Important safety information
Once weekly
Semaglutide (Wegovy, Ozempic). FDA-approved since 2017, with the most published evidence of any GLP-1. Once-weekly injection.
Publications covering the GLP-1 category
Why GLP1Zoom
We compare 12+ GLP-1 telehealth partners side-by-side. No partner can pay to rank higher; editorial ratings are independent of commission rate.
GLP1Zoom earns commission when you sign up via a partner. Your price does not change. Clicking a partner button redirects you directly to that company.
GLP1Zoom is not a healthcare provider, pharmacy, or insurance plan. We do not sell, prescribe, dispense, or process payments — partners do that, on their websites.
Manufacturer-direct option
Starting at $299/mo for the lowest-dose vial purchased directly from Eli Lilly. Telehealth partners list comparable plans from $349/mo with prescriber visits included. Pricing varies by dose and pharmacy — confirm before purchase.
From research to first dose, typically under 7 days.
Answer 3 questions about your goals, insurance, and budget. We match you to the right medication + provider.
Start quizSee real-time pricing across telehealth providers. FDA-approved brand or compounded — your choice. Filter by state, dosage, shipping speed.
See providersFive questions. We'll rank the top 3 GLP-1s that match your goals, insurance, and clinical fit.
Step 1 of 5
Example scenarios based on typical GLP1Zoom user experiences. Names, locations, and savings figures are illustrative — not from specific identified users. Real testimonials will replace these as we gather them with consent.
“Found Zepbound for $299/mo through Mochi — $700 less than my pharmacy quoted.”
Jessica M.
Texas
“The AI Q&A answered my drug interaction question in seconds. Saved a doctor visit.”
$0
Americans have saved on GLP-1 medications using GLP1Zoom since 2024.
Avg savings per GLP1Zoom user: $400/mo off retail GLP-1 prices.
Read about our impact12,000+
Readers since 2024
50
US states covered
12
Telehealth providers
18
GLP-1 medications
GoodRx is general pharmacy comparison. Telehealth providers sell direct. GLP1Zoom is the only GLP-1-specialist comparison + tool layer.
| Feature | GLP1Zoom recommended | GoodRx | Telehealth (direct) |
|---|---|---|---|
| GLP-1 specialist | ~ | ||
| Compare 12 providers side-by-side |
Medications
Providers
Editorial
GLP1Zoom is a comparison site for GLP-1 medications and telehealth providers. We don't prescribe, sell, or ship drugs ourselves. We earn affiliate commission when you sign up via partner providers.
18
medications
Live FDA monitoring
Every drug page (18 GLP-1 + GIP/GLP-1 products) checks FDA shortage and enforcement status on every load. Compounded options carry explicit disclaimers.
4
clinicians
MD-reviewed content
A four-clinician editorial board signs off on every clinical claim before publishing. See the Medical Review Board page for credentials.
$0
cost to readers
Free + no signup
All comparisons, calculators, and AI Q&A are free. No paywall, no credit card, no data sold to third parties.
Live • last 24h

$69/mo
LOWESTSnapshot of current partner-network cash-pay prices. Final price depends on dose, plan, and partner offer at signup — verify on the partner's website (direct redirect).
Browse by goal
Six common goals, six curated drug shortlists. Tap to read the editorial review for the best fit in each category.
Highest-efficacy GLP-1s for substantial weight loss. Tirzepatide leads in trial data.
Read review →
GLP-1s with FDA approval for glycemic control. Some also cardio-protective.
Read review →
GLP-1s with FDA label for reducing cardiovascular events.
Partner network
Honest about what we are
30-second filter
Pick one. We'll line up the partners and FDA-approved options that match your priority. (Not medical screening — preference filter only.)
30 seconds
Tell us your state, budget, FDA preference, and medication priority. We'll line up the partners with the best fit. No signup. No medical screening — preference filter only.
No signup · No PII stored
Quick check
FDA-label thresholds: BMI ≥30 (obesity) or ≥27 with a weight-related condition (hypertension, type 2 diabetes, sleep apnea). Eligibility is determined by your prescriber, not by this calculator.
No data leaves your browser. We don't store, send, or sell what you type here.
—
Informational only. Final eligibility is determined by a licensed clinician at the partner you choose — not by GLP1Zoom.
Composite case studies
These are composite profiles — representative aggregates synthesized from public reviews, forum threads, and partner outcome reports. They are not individual endorsements.
↓ 20% body weight
in 12 months
40s · TX
Composite — combines 30+ user reports
“The comparison made the partner pricing transparent. I picked the one with shipping included; the redirect took me straight to their intake — GLP1Zoom not handled anything personal.”
Drug: Tirzepatide via partner network
Trial source: SURMOUNT-1
↓ 14% body weight
in 8 months
50s · CA
In 2025, picking a GLP-1 telehealth provider meant comparing 12+ partner offers across 50 state regulatory frameworks, with cash-pay prices ranging from $199 to $1,200 a month. Most comparison sites at the time either took partner placement fees that shaped rankings — or were affiliate sites that didn't say so loudly enough.
We started GLP1Zoom with two rules. One: editorial ratings would be independent of commission rate; reviewers paid a flat fee, not equity. Two: the affiliate model would be disclosed in plain English on every partner card — not buried in a privacy policy.
We're a comparison site. We don't prescribe, dispense, or process payments — that's the partner's job. Our job is to line them up honestly, verify their prices monthly, and explain what GLP-1s actually do, in language a 9th-grader would follow.
US coverage
Click your state for partners that operate there. Coverage and pricing vary by state telehealth law — we verify monthly.
Editorial board
Every drug page is reviewed by a US-licensed clinician, pharmacist, or RD before publication. Editorial reviewers do not endorse any partner provider and have no commercial relationship with GLP1Zoom's affiliate revenue.
Board-Certified, Internal Medicine
Medical Reviewer — endocrine & metabolic content
Reviews diabetes and obesity content for clinical accuracy against current FDA labels.
Doctor of Pharmacy, MPH
Pharmacy Reviewer — drug interaction & dosing content
Verifies dose titration schedules, drug interactions, and pharmacy-related claims.
Registered Dietitian, Certified Diabetes Educator
Nutrition Reviewer — lifestyle & adherence content
Reviews diet, lifestyle, and patient-adherence guidance accompanying medication content.
The GLP1Zoom weekly
Weekly editorial round-up — partner price changes, new FDA labels, drug-shortage updates, and one independent take. No medical advice; no spam.
Every clinical claim is reviewed by a licensed clinician. Pricing re-verified with each provider monthly. Compounded medication content carries explicit FDA disclaimers.
Compounded semaglutide and tirzepatide via 503A/503B pharmacies. Lower price, important FDA caveats.
Starting from
$149/mo
View comparisonThese are independent telehealth providers — we earn affiliate commission when you sign up via partner links. Editorial ratings are independent of partnerships. Prices sourced from public provider pages and verified weekly. Read our affiliate disclosure.
From $299/mo via partner network · Important safety information
Editorial references. Logos shown for category context — not endorsement of GLP1Zoom.
No data sold
Privacy-first analytics
Use insurance lookup, manufacturer savings cards, and copay programs to minimize out-of-pocket cost.
Check coverageYour chosen provider runs the telehealth eval, writes the Rx, and ships to your door — not GLP1Zoom. Most partner providers offer same-week start.
Get started| $998 |
| Mounjaro | GIP/GLP-1 | $399/mo | $1069 |
| Rybelsus | Oral GLP-1 | $419/mo | $998 |
Reference prices only — actual costs vary by provider, plan, dosage, and state. As of Jun 2026. GLP1Zoom does not sell medications; we connect users to provider partners via affiliate links.
Marcus T.
California
“Compared 4 telehealth providers in 10 minutes. Mochi had the cleanest pricing.”
Priya S.
New York
| AI Q&A trained on FDA labels |
| Live FDA enforcement monitoring |
| Insurance lookup across plans | ~ |
| Drug interaction checker |
| Price history charts (90d, 1y) | ~ |
| US price heat map by state |
| Bariatric surgery comparison |
| Editorial reviewed by MD | ~ |
| Free, no signup |
Feature set as of June 2026. We update this matrix quarterly.
In stock via 8 providers
exenatide ER

Popular
Popular
In stock via 11 providers
semaglutide (compounded)
PopularIn stock via 8 providers
tirzepatide (compounded)
Scroll to see more. "In stock" reflects average partner availability; confirm current availability with each provider.
$199/mo
Read review →
Partner trademarks belong to their respective owners. We do not sell, prescribe, or process payments — clicking a partner redirects you directly to that company's website.
Composite — aggregated from public reviews
“I wanted FDA-approved only. The filter narrowed to three partners. The cheapest was $349/mo and the partner handled all the prescribing on their site.”
Drug: Semaglutide via partner network
Trial source: STEP-1
↓ Target dose reached
in month 5
30s · FL
Composite — synthesized from forum threads
“The dose-titration explainer was clearer than what I got from my partner intake. Knowing the schedule ahead of time made me feel ready for the side effects.”
Drug: Tirzepatide via partner network
Trial source: SURMOUNT titration protocol
Outcomes are class-typical figures from FDA-approved trial data (SURMOUNT-1, STEP-1, SCALE) — not the experience of a single individual. Individual results vary widely.
If we ever drift from those rules, you'll see it in the corrections log. Email [email protected] if you spot a drift.
Coverage figures are aggregated across the GLP1Zoom partner network. Individual partner availability differs — check the partner's website for definitive state coverage.
Health Law, JD
Regulatory Reviewer — FDA, FTC, state pharmacy law
Cross-checks FDA approval status, state pharmacy practice rules, and compliance disclosures.
Reviewers are independent contractors paid a flat editorial fee — not commission. See our Editorial Policy · Medical Review Board.